Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Curon Picks Up China-Plus Rights to Rhi
NEW YORK – Moves by Japan to offer better guidelines and accelerated approvals for regenerative medicine are creating an environment conducive to investment and attractive to companies. “In Japan you
NEW YORK – Moves by Japan to offer better guidelines and accelerated approvals for regenerative medicine is creating an environment conducive for investment and attractive to companies. “In Japan you
IN VITRO DIAGNOSTICS Mergers & Acquisitions Metamark Genetics Inc. Endo Health Solutions Inc. HealthTronics Inc. HealthTronics Laboratory Solutions Endo International PLC (branded and generic drug